| Gilead Sciences Switzerland Sàrl - Hepcludex 2 mg, Pulver zur Herstellung einer Injektionslösung |
| 68338 | | 01 | | Hepcludex 2 mg | | Pulver zur Herstellung einer Injektionslösung | | J05AX28 | | Bulevirtide | | 05.02.2024 | | |
|
| Composition |
| bulevirtidum 2 mg ut bulevirtidi acetas, natrii carbonas, natrii hydrogenocarbonas, mannitolum, pro vitro corresp. natrium 0.63 mg. |
| Packungsbestandteile |
| Dry substance | | | | | | | | Active Agent | Dose |
|---|
| Bulevirtidum | 2 mg |
| | BAG: Active Agent | Dose |
|---|
| Bulevirtidum | 2 mg |
| | | | Inactive agents |
|---|
| Mannitol | | Sodium Carbonate | | Sodium Hydrogen Carbonate |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | 5449.37 | 5898.85 | A | SL | No |
|
